Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
(NASDAQ: DTIL) Delayed: 6.22 -0.11 (1.74%)
Previous Close $6.33    52 Week High $ 
Open $6.35    52 Week Low $ 
Day High $6.55    P/E N/A 
Day Low $6.18    EPS $ 
Volume 203,993